Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Dendritic Cell Sarcoma, Interdigitating × Irinotecan × 90 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 25 Pancreatic Neoplasms 15 Neuroblastoma 9 Neoplasm Metastasis 9 Colonic Neoplasms 7 Stomach Neoplasms 6 Sarcoma, Ewing 6 Rhabdomyosarcoma 5 Rectal Neoplasms 5 Neoplasms 5 Medulloblastoma 4 Esophageal Squamous Cell Carcinoma 4 Sarcoma 3 Recurrence 3 Ovarian Neoplasms 3 Osteosarcoma 3 Esophageal Neoplasms 3 Ependymoma 3 Endometrial Neoplasms 3 Cholangiocarcinoma 3 Adenocarcinoma Of Esophagus 3 Wilms Tumor 2 Uterine Cervical Neoplasms 2 Small Cell Lung Carcinoma 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Fibrolamellar hepatocellular carcinoma 2 Colorectal Adenocarcinoma 2 Breast Neoplasms 2 Biliary Tract Neoplasms 2

Interventions

Rituximab 2 Cyclophosphamide 2 zanubrutinib 1 venetoclax 1 relmacabtagene autoleucel 1 pirtobrutinib 1 pembrolizumab 1 pegfilgrastim 1 obinutuzumab 1 glofitamab 1 fludarabine 1 axicabtagene ciloleucel 1 Whole-Body Irradiation 1 Vincristine 1 Triamcinolone 1 Tacrolimus 1 Prednisolone 1 Mycophenolic Acid 1 Melphalan 1 Lenalidomide 1 Granulocyte Colony-Stimulating Factor 1 Doxorubicin 1 Dexrazoxane 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡